Home
About Us
Company Culture
Milestones
Awards and Honors
Social Responsibility
Talent Development
Hot
Recombinant Protein Product
Research and Innovation
R&D Team
Pipelines
Product Category
Drug Products
Peginterferon Alfa-2b Injection
Pegsomatropin Injection
Pegfilgrastim Injection
Molgramostim
Filgrastim
Oprelvekin
API
Reagents
Growth Factors
Interleukins
Interferons
Enzymes
Others
News
Contact Us
English
简体中文
Home
/
News
News and Events
Pegberon" supports CHB standard treatment in the "interferon clinical application
2017
09-01
Read More
Amoytop Biotech: Success after 14 years
2017
08-17
Read More
PR Newswire: Clinical effect of Pegberon® (Pegylated Interferon), China's Independent Intellectual Property, has been recognized by experts
2017
08-17
Read More
Gather Chinese wisdom to realize higher treatment goals for CHB
2017
08-17
Read More
«
1
...
6
7
8
...
11
»
Facebook
Twitter
LinkedIn
Instagram
WELCOME
Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Fax: +86-592-6889110
international@amoytop.com
Tel: +86-592-6889106
Copyright ©
2023
Amoytop Biotech All Rights Reserved. Support by
Leadong
｜
Sitemap
.
Privacy Policy
Email
international@amoytop.com
reagent@amoytop.com
Tel
+86-592-6889106
cell Phone
+86-18060918257
Leave a Message
Get In Touch
Submit
